{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:52:02Z","timestamp":1793843522814,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005273","name":"Natural Science Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["202301BA070001-133"],"award-info":[{"award-number":["202301BA070001-133"]}],"id":[{"id":"10.13039\/501100005273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010617","name":"Dali University","doi-asserted-by":"publisher","award":["KYBS2021101"],"award-info":[{"award-number":["KYBS2021101"]}],"id":[{"id":"10.13039\/501100010617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-024-02188-y","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T08:34:43Z","timestamp":1732264483000},"page":"2258-2273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Uncovering the Mechanism of Scopoletin in Ameliorating Psoriasis-Like Skin Symptoms via Inhibition of PI3K\/Akt\/mTOR Signaling Pathway"],"prefix":"10.1007","volume":"48","author":[{"given":"Dongna","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaimei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianquan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"2188_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes, M.A., M. Su\u00e1rez-Fari\u00f1as, and J.G. Krueger. 2014. Immunology of psoriasis. Annual Review of Immunology 32: 227\u2013255. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120225.","journal-title":"Annual Review of Immunology"},{"issue":"19","key":"2188_CR2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A.W., and C. Read. 2020. Pathophysiology, clinical presentation, and treatment of psoriasis: A review. JAMA 323 (19): 1945\u20131960. https:\/\/doi.org\/10.1001\/jama.2020.4006.","journal-title":"JAMA"},{"issue":"4","key":"2188_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11926-005-0044-5","volume":"7","author":"TT Leong","year":"2005","unstructured":"Leong, T.T., U. Fearon, and D.J. Veale. 2005. Angiogenesis in psoriasis and psoriatic arthritis: Clues to disease pathogenesis. Current Rheumatology Reports 7 (4): 325\u2013329. https:\/\/doi.org\/10.1007\/s11926-005-0044-5.","journal-title":"Current Rheumatology Reports"},{"issue":"5","key":"2188_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1600-0625.2012.01459.x","volume":"21","author":"Y Dombrowski","year":"2012","unstructured":"Dombrowski, Y., and J. Schauber. 2012. Cathelicidin LL-37: A defense molecule with a potential role in psoriasis pathogenesis. Experimental Dermatology 21 (5): 327\u2013330. https:\/\/doi.org\/10.1111\/j.1600-0625.2012.01459.x.","journal-title":"Experimental Dermatology"},{"key":"2188_CR5","doi-asserted-by":"publisher","first-page":"788940","DOI":"10.3389\/fimmu.2021.788940","volume":"12","author":"P Hu","year":"2021","unstructured":"Hu, P., M. Wang, H. Gao, A. Zheng, J. Li, D. Mu, and J. Tong. 2021. The role of helper T cells in psoriasis. Frontiers in Immunology 12: 788940. https:\/\/doi.org\/10.3389\/fimmu.2021.788940.","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"2188_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2340\/00015555-1737","volume":"94","author":"T Huang","year":"2014","unstructured":"Huang, T., X. Lin, X. Meng, and M. Lin. 2014. Phosphoinositide-3 kinase\/protein kinase-B\/mammalian target of rapamycin pathway in psoriasis pathogenesis. A potential therapeutic target? Acta Dermato-Venereologica 94 (4): 371\u2013379. https:\/\/doi.org\/10.2340\/00015555-1737.","journal-title":"Acta Dermato-Venereologica"},{"issue":"1","key":"2188_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cyto.2012.06.316","volume":"60","author":"A Mitra","year":"2012","unstructured":"Mitra, A., S.K. Raychaudhuri, and S.P. Raychaudhuri. 2012. IL-22 induced cell proliferation is regulated by PI3K\/Akt\/mTOR signaling cascade. Cytokine 60 (1): 38\u201342. https:\/\/doi.org\/10.1016\/j.cyto.2012.06.316.","journal-title":"Cytokine"},{"issue":"8","key":"2188_CR8","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.3390\/ijms22083968","volume":"22","author":"HR Kim","year":"2021","unstructured":"Kim, H.R., J.C. Kim, S.Y. Kang, H.O. Kim, C.W. Park, and B.Y. Chung. 2021. Rapamycin alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced aggravated dermatitis in mice with imiquimod-induced psoriasis-like dermatitis by inducing autophagy. International Journal of Molecular Sciences 22 (8): 3968. https:\/\/doi.org\/10.3390\/ijms22083968.","journal-title":"International Journal of Molecular Sciences"},{"key":"2188_CR9","doi-asserted-by":"publisher","first-page":"102916","DOI":"10.1016\/j.jaut.2022.102916","volume":"133","author":"J Yu","year":"2022","unstructured":"Yu, J., Q. Zhao, X. Wang, H. Zhou, J. Hu, L. Gu, Y. Hu, F. Zeng, F. Zhao, C. Yue, P. Zhou, G. Li, Y. Li, W. Wu, Y. Zhou, and J. Li. 2022. Pathogenesis, multi-omics research, and clinical treatment of psoriasis. Journal of Autoimmunity 133: 102916. https:\/\/doi.org\/10.1016\/j.jaut.2022.102916.","journal-title":"Journal of Autoimmunity"},{"issue":"3","key":"2188_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2165\/00128071-200203030-00001","volume":"3","author":"C Levin","year":"2002","unstructured":"Levin, C., and H.I. Maibach. 2002. Topical corticosteroid-induced adrenocortical insufficiency: Clinical implications. American Journal of Clinical Dermatology 3 (3): 141\u2013147. https:\/\/doi.org\/10.2165\/00128071-200203030-00001.","journal-title":"American Journal of Clinical Dermatology"},{"issue":"4","key":"2188_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","volume":"60","author":"A Menter","year":"2009","unstructured":"Menter, A., N.J. Korman, C.A. Elmets, S.R. Feldman, J.M. Gelfand, K.B. Gordon, A. Gottlieb, J.Y.M. Koo, M. Lebwohl, H.W. Lim, A.S. Van Voorhees, and R. Bhushan. 2009. Guidelines of care for the management of psoriasis and psoriatic arthritis Stion 3 Guidelines of care for the management and treatment of psoriasis with topical therapies. Journal of the American Academy of Dermatology 60 (4): 643\u2013659. https:\/\/doi.org\/10.1016\/j.jaad.2008.12.032.","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Suppl. 2","key":"2188_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1468-3083.2011.03992.x","volume":"25","author":"A Maza","year":"2011","unstructured":"Maza, A., H. Montaudi\u00e9, E. Sbidian, A. Gallini, S. Aractingi, F. Aubin, H. Bachelez, B. Cribier, P. Joly, D. Jullien, M. Le Ma\u00eetre, L. Misery, M.A. Richard, J.P. Ortonne, and C. Paul. 2011. Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. Journal of the European Academy of Dermatology and Venereology 25 (Suppl. 2): 19\u201327. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.03992.x.","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1","key":"2188_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jaad.2015.03.049","volume":"73","author":"K Papp","year":"2015","unstructured":"Papp, K., K. Reich, C.L. Leonardi, L. Kircik, S. Chimenti, R.G.B. Langley, C. Hu, R.M. Stevens, R.M. Day, K.B. Gordon, N.J. Konrman, and C.E.M. Griffiths. 2015. Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (efficacy and safety trial evaluating the effects of apremilast in psoriasis [ESTEEM] 1). Journal of the American Academy of Dermatology 73 (1): 37\u201349. https:\/\/doi.org\/10.1016\/j.jaad.2015.03.049.","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"2188_CR14","doi-asserted-by":"publisher","first-page":"0153740","DOI":"10.1371\/journal.pone.0153740","volume":"11","author":"J West","year":"2016","unstructured":"West, J., S. Ogston, and J. Foerster. 2016. Safety and efficacy of methotrexate in psoriasis: A meta-analysis of published trials. PLoS ONE 11 (5): 0153740. https:\/\/doi.org\/10.1371\/journal.pone.0153740.","journal-title":"PLoS ONE"},{"issue":"4","key":"2188_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1046\/j.1365-2133.1997.6101586.x","volume":"136","author":"H Zachariae","year":"1997","unstructured":"Zachariae, H., K. Kragballe, H.E. Hansen, N. Marcussen, and S. Olsen. 1997. Renal biopsy findings in long-term cyclosporin treatment of psoriasis. The British Journal of Dermatology 136 (4): 531\u2013535. https:\/\/doi.org\/10.1046\/j.1365-2133.1997.6101586.x.","journal-title":"The British Journal of Dermatology"},{"issue":"9","key":"2188_CR16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamadermatol.2015.0718","volume":"151","author":"RE Kalb","year":"2015","unstructured":"Kalb, R.E., D.F. Fiorentino, M.G. Lebwohl, J. Toole, Y. Poulin, A.D. Cohen, K. Goyal, S. Fakharzadeh, S. Calabro, M. Chevrier, W. Langholff, Y. You, and C.L. Leonardi. 2015. Risk of serious infection with biologic and systemic treatment of psoriasis: Results from the psoriasis longitudinal assessment and registry (PSOLAR). JAMA Dermatology 151 (9): 961\u2013969. https:\/\/doi.org\/10.1001\/jamadermatol.2015.0718.","journal-title":"JAMA Dermatology"},{"issue":"4","key":"2188_CR17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1056\/NEJMoa1314258","volume":"371","author":"RG Langley","year":"2014","unstructured":"Langley, R.G., B.E. Elewski, M. Lebwohl, K. Reich, C.E.M. Griffiths, K. Papp, L. Puig, H. Nakagawa, L. Spelman, B. Sigurgeiresson, E. Rivas, T.F. Tsai, N. Wasel, S. Tyring, T. Salko, I. Hampele, M. Notter, A. Karpov, S. Helou, C. Papavassilis, E.S. Group, and F.S. Group. 2014. Secukinumab in plaque psoriasis\u2013results of two phase 3 trials. The New England Journal of Medicine 371 (4): 326\u2013338. https:\/\/doi.org\/10.1056\/NEJMoa1314258.","journal-title":"The New England Journal of Medicine"},{"issue":"21","key":"2188_CR18","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1056\/NEJMoa030409","volume":"349","author":"CL Leonardi","year":"2003","unstructured":"Leonardi, C.L., J.L. Powers, R.T. Matheson, B.S. Goffe, R. Zitnik, A. Wang, A.B. Gottlieb, E.P.S. Group. 2003. Etanercept as Monotherapy in Patients with Psoriasis. The New England Journal of Medicine 349 (21): 2014\u20132022. https:\/\/doi.org\/10.1056\/NEJMoa030409.","journal-title":"The New England Journal of Medicine"},{"key":"2188_CR19","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3389\/fphar.2020.01035","volume":"11","author":"KX Wang","year":"2020","unstructured":"Wang, K.X., Y. Gao, C. Lu, Y. Li, B.Y. Zhou, X.M. Qin, G.H. Du, L. Gao, D.G. Guang, and A.P. Lu. 2020. Uncovering the complexity mechanism of different formulas treatment for rheumatoid arthritis based on a novel network pharmacology model. Frontiers in Pharmacology 11: 1035. https:\/\/doi.org\/10.3389\/fphar.2020.01035.","journal-title":"Frontiers in Pharmacology"},{"issue":"10","key":"2188_CR20","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1002\/ptr.7546","volume":"36","author":"Y Chen","year":"2022","unstructured":"Chen, Y., S. Song, Y. Wang, J. Zhu, and X. Li. 2022. Potential mechanism of oral baicalin treating psoriasis via suppressing Wnt signaling pathway and inhibiting Th17\/IL-17 axis by activating PPAR\u03b3. Phytotherapy Research 36 (10): 3969\u20133987. https:\/\/doi.org\/10.1002\/ptr.7546.","journal-title":"Phytotherapy Research"},{"key":"2188_CR21","doi-asserted-by":"publisher","first-page":"114041","DOI":"10.1016\/j.jep.2021.114041","volume":"274","author":"KS Qu","year":"2021","unstructured":"Qu, K.S., Y. Luo, X.N. Yan, L. Kuai, Y. Ru, Y. Luo, J.K. Song, W.L. Ji, B. Li, and M. Xing. 2021. Qinzhuliangxue mixture alleviates psoriasis-like skin lesions via inhibiting the IL6\/STAT3 axis. Journal of Ethnopharmacology 274: 114041. https:\/\/doi.org\/10.1016\/j.jep.2021.114041.","journal-title":"Journal of Ethnopharmacology"},{"key":"2188_CR22","doi-asserted-by":"publisher","first-page":"114571","DOI":"10.1016\/j.jep.2021.114571","volume":"281","author":"C Song","year":"2021","unstructured":"Song, C., C. Yang, S. Meng, M. Li, X. Wang, Y. Zhu, L. Kong, W. Lv, H. Qiao, and Y. Sun. 2021. Deciphering the mechanism of Fang-Ji-Di-Huang-Decoction in ameliorating psoriasis-like skin inflammation via the inhibition of IL-23\/Th17 cell axis. Journal of Ethnopharmacology 281: 114571. https:\/\/doi.org\/10.1016\/j.jep.2021.114571.","journal-title":"Journal of Ethnopharmacology"},{"key":"2188_CR23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.molimm.2018.07.011","volume":"101","author":"XJ Xie","year":"2018","unstructured":"Xie, X.J., T.T. Di, Y. Wang, M.X. Wang, Y.J. Meng, Y. Lin, X.L. Xu, P. Li, and J. Zhao. 2018. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing \u03b3\u03b4 T cells. Molecular Immunology 101: 386\u2013395. https:\/\/doi.org\/10.1016\/j.molimm.2018.07.011.","journal-title":"Molecular Immunology"},{"issue":"1","key":"2188_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12934-022-01865-7","volume":"21","author":"BT He","year":"2022","unstructured":"He, B.T., Z.H. Liu, B.Z. Li, and Y.J. Yuan. 2022. Advances in biosynthesis of scopoletin. Microbial Cell Factories 21 (1): 152. https:\/\/doi.org\/10.1186\/s12934-022-01865-7.","journal-title":"Microbial Cell Factories"},{"issue":"10","key":"2188_CR25","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3390\/biomedicines9101412","volume":"9","author":"TP Hsueh","year":"2021","unstructured":"Hsueh, T.P., W.L. Lin, J.W. Dalley, and T.H. Tsai. 2021. The pharmacological effects and pharmacokinetics of active compounds of Artemisia capillaris. Biomedicines 9 (10): 1412. https:\/\/doi.org\/10.3390\/biomedicines9101412.","journal-title":"Biomedicines"},{"issue":"7\u20138","key":"2188_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1515\/znc-2021-0193","volume":"77","author":"LD Antika","year":"2022","unstructured":"Antika, L.D., A.N. Tasfiyati, H. Hikmat, and A.W. Septama. 2022. Scopoletin: A review of its source, biosynthesis, methods of extraction, and pharmacological activities. Zeitschrift Fur Naturforschung C 77 (7\u20138): 303\u2013316. https:\/\/doi.org\/10.1515\/znc-2021-0193.","journal-title":"Zeitschrift Fur Naturforschung C"},{"issue":"4","key":"2188_CR27","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.intimp.2013.10.011","volume":"17","author":"Y Dou","year":"2013","unstructured":"Dou, Y., B. Tong, Z. Wei, Y. Li, Y. Xia, and Y. Dai. 2013. Scopoletin suppresses IL-6 production from fibroblast-like synoviocytes of adjuvant arthritis rats induced by IL-1\u03b2 stimulation. International Immunopharmacology 17 (4): 1037\u20131043. https:\/\/doi.org\/10.1016\/j.intimp.2013.10.011.","journal-title":"International Immunopharmacology"},{"key":"2188_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejphar.2018.07.032","volume":"834","author":"JH Jang","year":"2018","unstructured":"Jang, J.H., J.E. Park, and J.S. Han. 2018. Scopoletin inhibits \u03b1-glucosidase in vitro and alleviates postprandial hyperglycemia in mice with diabetes. European Journal of Pharmacology 834: 152\u2013156. https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.032.","journal-title":"European Journal of Pharmacology"},{"key":"2188_CR29","doi-asserted-by":"publisher","first-page":"119105","DOI":"10.1016\/j.lfs.2021.119105","volume":"270","author":"C Yuan","year":"2021","unstructured":"Yuan, C., M.H. Wang, F. Wang, P.Y. Chen, X.G. Ke, B. Yu, Y.F. Yang, P.T. You, and H.Z. Wu. 2021. Network pharmacology and molecular docking reveal the mechanism of scopoletin against non-small cell lung cancer. Life Sciences 270: 119105. https:\/\/doi.org\/10.1016\/j.lfs.2021.119105.","journal-title":"Life Sciences"},{"key":"2188_CR30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fphar.2019.00863","volume":"10","author":"F Zhang","year":"2019","unstructured":"Zhang, F., Y. Zhang, T. Yang, Z.Q. Ye, J. Tian, H.R. Fang, J.J. Han, Z.Z. Wang, and X. Li. 2019. Scopoletin suppresses activation of dendritic cells and pathogenesis of experimental autoimmune encephalomyelitis by inhibiting NF-\u03baB signaling. Frontiers in Pharmacology 10: 863. https:\/\/doi.org\/10.3389\/fphar.2019.00863.","journal-title":"Frontiers in Pharmacology"},{"issue":"11","key":"2188_CR31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins, A.L. 2008. Network pharmacology: The next paradigm in drug discovery. Nature Chemical Biology 4 (11): 682\u2013690. https:\/\/doi.org\/10.1038\/nchembio.118.","journal-title":"Nature Chemical Biology"},{"key":"2188_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2019.00123","volume":"10","author":"R Zhang","year":"2019","unstructured":"Zhang, R., X. Zhu, H. Bai, and K. Ning. 2019. Network pharmacology databases for traditional Chinese medicine: Review and assessment. Frontiers in Pharmacology 10: 123. https:\/\/doi.org\/10.3389\/fphar.2019.00123.","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"2188_CR33","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12931-021-01781-1","volume":"22","author":"H Zhu","year":"2021","unstructured":"Zhu, H., S. Wang, C. Shan, X. Li, B. Tan, Q. Chen, Y. Yang, H. Yu, and A. Yang. 2021. Mechanism of protective effect of xuan-bai-cheng-qi decoction on LPS-induced acute lung injury based on an integrated network pharmacology and RNA-sequencing approach. Respiratory Research 22 (1): 188. https:\/\/doi.org\/10.1186\/s12931-021-01781-1.","journal-title":"Respiratory Research"},{"issue":"9","key":"2188_CR34","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L., S. Mourits, J.S.A. Voerman, M. Kant, L. Boon, J.D. Laman, F. Cornelissen, A.M. Mus, E. Florencia, E.P. Prens, and E. Lubberts. 2009. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. The Journal of Immunology 182 (9): 5836\u20135845. https:\/\/doi.org\/10.4049\/jimmunol.0802999.","journal-title":"The Journal of Immunology"},{"issue":"W1","key":"2188_CR35","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong, G., Z. Wu, J. Yi, L. Fu, Z. Yang, C. Hsieh, M. Yin, X. Zeng, C. Wu, A. Lu, X. Chen, T. Hou, and D. Cao. 2021. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Research 49 (W1): W5\u2013W14. https:\/\/doi.org\/10.1093\/nar\/gkab255.","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"2188_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/aps.2016.126","volume":"38","author":"YC Zeng","year":"2017","unstructured":"Zeng, Y.C., S. Li, C. Liu, T. Gong, X. Sun, Y. Fu, and Z.R. Zhang. 2017. Soluplus micelles for improving the oral bioavailability of scopoletin and their hypouricemic effect in vivo. Acta Pharmacologica Sinica 38 (3): 424\u2013433. https:\/\/doi.org\/10.1038\/aps.2016.126.","journal-title":"Acta Pharmacologica Sinica"},{"key":"2188_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuint.2016.01.001","volume":"93","author":"M Basu","year":"2016","unstructured":"Basu, M., K. Mayana, S. Xavier, S. Balachandran, and N. Mishra. 2016. Effect of scopoletin on monoamine oxidases and brain amines. Neurochemistry International 93: 113\u2013117. https:\/\/doi.org\/10.1016\/j.neuint.2016.01.001.","journal-title":"Neurochemistry International"},{"key":"2188_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.indcrop.2015.03.039","volume":"70","author":"S Jamuna","year":"2015","unstructured":"Jamuna, S., K. Karthika, S. Paulsamy, K. Thenmozhi, S. Kathiravan, and R. Venkatesh. 2015. Confertin and scopoletin from leaf and root extracts of Hypochaeris radicata have anti-inflammatory and antioxidant activities. Industrial Crops and Products 70: 221\u2013230. https:\/\/doi.org\/10.1016\/j.indcrop.2015.03.039.","journal-title":"Industrial Crops and Products"},{"issue":"Suppl. 2","key":"2188_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/s0001-7310(09)73372-1","volume":"100","author":"RKH Mak","year":"2009","unstructured":"Mak, R.K.H., C. Hundhausen, and F.O. Nestle. 2009. Progress in understanding the immunopathogenesis of psoriasis. Actas Dermo-sifiliograficas 100 (Suppl. 2): 2\u201313. https:\/\/doi.org\/10.1016\/s0001-7310(09)73372-1.","journal-title":"Actas Dermo-sifiliograficas"},{"issue":"1","key":"2188_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.sder.2010.03.001","volume":"29","author":"KE Nograles","year":"2010","unstructured":"Nograles, K.E., B. Davidovici, and J.G. Krueger. 2010. New insights in the immunologic basis of psoriasis. Seminars in Cutaneous Medicine and Surgery 29 (1): 3\u20139. https:\/\/doi.org\/10.1016\/j.sder.2010.03.001.","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"issue":"4","key":"2188_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","volume":"12","author":"GM Delgoffe","year":"2011","unstructured":"Delgoffe, G.M., K.N. Pollizzi, A.T. Waickman, E. Heikamp, D.J. Meyers, M.R. Horton, B. Xiao, P.F. Worley, and J.D. Powell. 2011. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nature Immunology 12 (4): 295\u2013303. https:\/\/doi.org\/10.1038\/ni.2005.","journal-title":"Nature Immunology"},{"issue":"17","key":"2188_CR42","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/onc.2014.164","volume":"34","author":"KM Dodd","year":"2015","unstructured":"Dodd, K.M., J. Yang, M.H. Shen, J.R. Sampson, and A.R. Tee. 2015. mTORC1 drives HIF-1\u03b1 and VEGF-A signaling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene 34 (17): 2239\u20132250. https:\/\/doi.org\/10.1038\/onc.2014.164.","journal-title":"Oncogene"},{"key":"2188_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","volume":"4","author":"J Karar","year":"2011","unstructured":"Karar, J., and A. Maity. 2011. PI3K\/AKT\/mTOR pathway in angiogenesis. Frontiers in Molecular Neuroscience 4: 51. https:\/\/doi.org\/10.3389\/fnmol.2011.00051.","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"10","key":"2188_CR44","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1038\/sj.jid.5700874","volume":"127","author":"C Rosenberger","year":"2007","unstructured":"Rosenberger, C., C. Solovan, A.D. Rosenberger, J. Li, R. Treudler, U. Frei, K.U. Eckardt, and L.F. Brown. 2007. Upregulation of hypoxia-inducible factors in normal and psoriatic skin. The Journal of Investigative Dermatology 127 (10): 2445\u20132452. https:\/\/doi.org\/10.1038\/sj.jid.5700874.","journal-title":"The Journal of Investigative Dermatology"}],"updated-by":[{"DOI":"10.1007\/s10753-024-02225-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000}}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02188-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02188-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02188-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T02:24:12Z","timestamp":1754879052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02188-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2188"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02188-y","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10753-024-02225-w","asserted-by":"object"}]},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"28 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10753-024-02225-w","URL":"https:\/\/doi.org\/10.1007\/s10753-024-02225-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}